Logo
Login
$STTK
$5.77 +$0.23 (4.15%) Close

Company Executives

$STTK Management Team

Mr. Andrew Neill

Chief Financial Officer

Age 39
Compensation $2.053M USD
Sex Male

Dr. Stephen Stout

General Counsel

Corporate Secretary and Chief Ethics and Compliance Officer

Age 50
Compensation -
Sex Male

Dr. George Golumbeski

Independent Chairman of the Board

Age 68
Compensation $171.1K USD
Sex Male

Dr. Taylor Schreiber

Chief Executive Officer

Co-Founder

Director

Age 45
Compensation $3.216M USD
Sex Male

Ms. Casi Deyoung

Chief Business Officer

Age 54
Compensation $523.5K USD
Sex Female

Dr. Arundathy Pandite

Chief Medical Officer

Age 66
Compensation $1.849M USD
Sex Female

Dr. Abhinav Shukla

Chief Technical Officer

Age 52
Compensation $1.199M USD
Sex Male

Mr. Conor Richardson

Senior Director

Finance & Investor Relations

Age -
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 8, 2026
Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
5.3 years
from year joined
CEO also chairs the board
No
George Golumbeski, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Taylor Schreiber, M.D., Ph.D.
CEO
 46 2017
9 years
 Not independent None stated None stated Paid as CEO
Mona Ashiya, Ph.D.
57 2025
1 year
 Independent None stated Yarrow Bioscience, Inc. $68,694
Daniel Baker, M.D.
75 2025
1 year
 Independent None stated None stated $72,528
Helen M. Boudreau
60 2020
6 years
 Independent None stated Rallybio Corp. $77,177
Neil Gibson, Ph.D.
69 2016
10 years
 Independent None stated TCR2 Therapeutics Inc., Causeway Therapeutics, Adanate, Inc., Instil Bio, Inc. $77,677
George Golumbeski, Ph.D.
Board chair
 68 2018
8 years
 Independent None stated Sage Therapeutics, Inc., Mural Oncology $99,677
Clay Siegall, Ph.D.
65 2024
2 years
 Independent None stated Immunome, Inc. $68,844

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 8, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans